FDA's Cosmetic AE Data Begs Question: What If Reporting Were Mandatory?

Infographic: According to FDA data, cosmetic-related AE reports in 2015 more than tripled what they were in 2009, but consumers still do the bulk of the reporting themselves. Proposed federal bills to update cosmetics oversight would require companies to report serious adverse events, which could propel numbers upward while providing FDA with greater insight into the marketplace.

Cosmetics reform bills under consideration in the US Congress invite speculation as to whether the marketplace picture would change dramatically if adverse-event reporting were required of companies.

Nakissa Sadrieh, director of the cosmetics program within FDA's Office of Cosmetics and Colors, presented data on cosmetic AE reporting in a March 7 keynote address at the American Conference...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation